Cardiovascular Revascularization Medicine
Volume 8, Issue 2 , Pages 90-93 , April 2007

Revascularization algorithm in acute STEMI should take into account age

  • Axel de Labriolle

      Affiliations

    • Département de Cardiologie, Centre Hospitalier Universitaire Tours, Tours, France
    • Corresponding Author InformationCorresponding author. Unité de soins intensifs cardiologiques, Centre Hospitalier Universitaire Trousseau, 37044 Tours, France. Tel.: +33 27 47 84 44; fax: +33 27 47 74 68.
    • ,
  • Bruno Giraudeau

      Affiliations

    • INSERM CIC 202, CHRU de Tours, Université François-Rabelais de Tours, Tours, France
    • ,
  • Gérard Pacouret

      Affiliations

    • Département de Cardiologie, Centre Hospitalier Universitaire Tours, Tours, France
    • ,
  • Bernard Desveaux

      Affiliations

    • Département de Cardiologie, Centre Hospitalier Universitaire Tours, Tours, France
    • ,
  • Laurent Quilliet

      Affiliations

    • Département de Cardiologie, Centre Hospitalier Universitaire Tours, Tours, France
    • ,
  • Bernard Charbonnier

      Affiliations

    • Département de Cardiologie, Centre Hospitalier Universitaire Tours, Tours, France
    • ,
  • Laurent Fauchier

      Affiliations

    • Département de Cardiologie, Centre Hospitalier Universitaire Tours, Tours, France

Received 6 December 2006 ,Accepted 12 December 2006.

References 

  1. Mehta RH, Granger CB, Alexander KP, Bossone E, White HD, Sketch MH. Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks. J Am Coll Cardiol. 2005;45:471–478
  2. The GUSTO investigators . An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673–682
  3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet. 1990;336:65–71
  4. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation. 1994;90:2103–2114
  5. Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, Krumholz HM. Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol. 2001;38:736–741
  6. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999;100:1016–1030
  7. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110:e82–e292
  8. Betriu A, Masotti M. Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis. Am J Cardiol. 2005;95:100–101
  9. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?. Am J Cardiol. 2003;92:824–826
  10. Nallamothu BK, Antman EM, Bates ER. Primary percutaneous coronary intervention versus fibrinolytic in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time to treatment?. Am J Cardiol. 2004;94:772–774
  11. De Luca G, Suryapranata H, Zijlstra F, van't Hof AW, Hoorntje JC, Gosselink AT, et al. Symptom onset to balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol. 2003;42:991–997
  12. Karha J, Topol EJ. Primary percutaneous coronary intervention vs. fibrinolytic therapy for acute ST-elevation myocardial infarction in the elderly. Am J Geriatr Cardiol. 2006;15:19–21
  13. Martinez-Selles M, Datino T, Bueno H. Influence of reperfusion therapy on prognosis in patients aged > or =89 years with acute myocardial infarction. Am J Cardiol. 2005;95:1232–1234
  14. Keeley EC, de Lemos JA. Free wall rupture in the elderly: deleterious effect of fibrinolytic therapy on the ageing heart. Eur Heart J. 2005;26:1693–1694
  15. Tarantini G, Razzolini R, Ramondo A, Napodano M, Bilato C, Iliceto S. Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-elevation acute myocardial infarction. Am J Cardiol. 2005;96:1503–1505
  16. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators . A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621–1628
  17. de Boer MJ, Ottervanger JP, van't Hof AW, Hoorntje JC, Suryapranata H, Zijlstra F Zwolle Myocardial Infarction Study Group. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002;39:1723–1728
  18. Berger AK, Schulman KA, Gersh BJ, Pirzada S, Breall JA, Johnson AE, et al. Primary coronary angioplasty versus thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA. 1999;282:341–348
  19. Mehta RH, Sadiq I, Goldberg RJ, Gore JM, Avezum A, Spencer F, et al. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J. 2004;147:253–259
  20. Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetgen WJ, Powe NR. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 2000;101:2239–2246

☆ None of the authors received any financial support for research, consultantships, and speakers forum from any pharmaceutical or material industry.

PII: S1553-8389(06)00272-7

doi: 10.1016/j.carrev.2006.12.002

Cardiovascular Revascularization Medicine
Volume 8, Issue 2 , Pages 90-93 , April 2007

Article Tools

* Image Usage & Resolution